Please provide your email address to receive an email when new articles are posted on . The overall risk for incident retinopathy in patients who received hydroxychloroquine for 5 or more years was ...

A new study found a connection between lower doses of hydroxychloroquine (HCQ) and increased risk of hospitalization in people with active systemic lupus erythematosus (SLE). HCQ (known commercially ...

Eye damage remains uncommon after 15 years, but certain factors increase the risk ...

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual scientific meeting, found that the recommended weight-based or non-weight-based dose of ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — In patients with systemic lupus erythematosus, lower doses of hydroxychloroquine increase the ...

Although lower HCQ doses became part of guidelines to counter the risk for long-term HCQ-induced retinopathy and vision loss, optimal dosing should be reassessed given these new findings, say the ...

A cohort study of more than 3,000 persons who received hydroxychloroquine for 5 or more years with guideline-recommended serial retinopathy screening found that the overall risk for incident ...

A new study likely makes the best estimate yet of the degree of retinopathy risk that patients who take the antimalarial drug hydroxychloroquine (HCQ) can expect, deriving mainly from the cumulative ...

This multicenter study investigates the association between hydroxychloroquine (HCQ) dosage and COVID-19 mortality among hospitalized patients in China, aiming to clarify conflicting evidence from ...

Retinal damage from taking hydroxychloroquine (HCQ) for more than 5 years occurred more frequently among people with certain characteristics, records from nearly 5,000 patients in the Kaiser ...